{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T22:25:59Z","timestamp":1770330359543,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,3,15]],"date-time":"2010-03-15T00:00:00Z","timestamp":1268611200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Syst Biol"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1752-0509-4-23","type":"journal-article","created":{"date-parts":[[2010,3,16]],"date-time":"2010-03-16T07:15:45Z","timestamp":1268723745000},"source":"Crossref","is-referenced-by-count":15,"title":["Two additive mechanisms impair the differentiation of 'substrate-selective' p38 inhibitors from classical p38 inhibitors in vitro"],"prefix":"10.1186","volume":"4","author":[{"given":"Bart S","family":"Hendriks","sequence":"first","affiliation":[]},{"given":"Kelly M","family":"Seidl","sequence":"additional","affiliation":[]},{"given":"Jeffrey R","family":"Chabot","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2010,3,15]]},"reference":[{"issue":"12","key":"412_CR1","first-page":"2398","volume":"33","author":"G Gartlehner","year":"2006","unstructured":"Gartlehner G, Hansen RA, Jonas BL, Thieda P, Lohr KN: The comparative efficacy and safety of biologics for the treatment of rheumatoid arthritis: a systematic review and metaanalysis. J Rheumatol. 2006, 33 (12): 2398-2408.","journal-title":"J Rheumatol"},{"issue":"15-16","key":"412_CR2","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.drudis.2006.06.002","volume":"11","author":"AT Paul","year":"2006","unstructured":"Paul AT, Gohil VM, Bhutani KK: Modulating TNF-alpha signaling with natural products. Drug Discov Today. 2006, 11 (15-16): 725-732. 10.1016\/j.drudis.2006.06.002","journal-title":"Drug Discov Today"},{"issue":"6","key":"412_CR3","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1128\/MCB.26.6.2399-2407.2006","volume":"26","author":"E Hitti","year":"2006","unstructured":"Hitti E, Iakovleva T, Brook M, Deppenmeier S, Gruber AD, Radzioch D, Clark AR, Blackshear PJ, Kotlyarov A, Gaestel M: Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine\/uridine-rich element. Mol Cell Biol. 2006, 26 (6): 2399-2407. 10.1128\/MCB.26.6.2399-2407.2006","journal-title":"Mol Cell Biol"},{"issue":"13","key":"412_CR4","doi-asserted-by":"publisher","first-page":"4827","DOI":"10.1128\/MCB.22.13.4827-4835.2002","volume":"22","author":"A Kotlyarov","year":"2002","unstructured":"Kotlyarov A, Yannoni Y, Fritz S, Laass K, Telliez JB, Pitman D, Lin LL, Gaestel M: Distinct cellular functions of MK2. Mol Cell Biol. 2002, 22 (13): 4827-4835. 10.1128\/MCB.22.13.4827-4835.2002","journal-title":"Mol Cell Biol"},{"issue":"18","key":"412_CR5","doi-asserted-by":"publisher","first-page":"4969","DOI":"10.1093\/emboj\/18.18.4969","volume":"18","author":"R Winzen","year":"1999","unstructured":"Winzen R, Kracht M, Ritter B, Wilhelm A, Chen CY, Shyu AB, Muller M, Gaestel M, Resch K, Holtmann H: The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. Embo J. 1999, 18 (18): 4969-4980. 10.1093\/emboj\/18.18.4969","journal-title":"Embo J"},{"issue":"10","key":"412_CR6","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.2174\/1568026054985894","volume":"5","author":"ST Wrobleski","year":"2005","unstructured":"Wrobleski ST, Doweyko AM: Structural comparison of p38 inhibitor-protein complexes: a review of recent p38 inhibitors having unique binding interactions. Curr Top Med Chem. 2005, 5 (10): 1005-1016. 10.2174\/1568026054985894","journal-title":"Curr Top Med Chem"},{"issue":"10","key":"412_CR7","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.2174\/1568026054985939","volume":"5","author":"DM Goldstein","year":"2005","unstructured":"Goldstein DM, Gabriel T: Pathway to the clinic: inhibition of P38 MAP kinase. A review of ten chemotypes selected for development. Curr Top Med Chem. 2005, 5 (10): 1017-1029. 10.2174\/1568026054985939","journal-title":"Curr Top Med Chem"},{"issue":"25","key":"412_CR8","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.2174\/092986705774462914","volume":"12","author":"MR Lee","year":"2005","unstructured":"Lee MR, Dominguez C: MAP kinase p38 inhibitors: clinical results and an intimate look at their interactions with p38alpha protein. Curr Med Chem. 2005, 12 (25): 2979-2994. 10.2174\/092986705774462914","journal-title":"Curr Med Chem"},{"issue":"4","key":"412_CR9","first-page":"421","volume":"8","author":"C Dominguez","year":"2005","unstructured":"Dominguez C, Powers DA, Tamayo N: p38 MAP kinase inhibitors: many are made, but few are chosen. Curr Opin Drug Discov Devel. 2005, 8 (4): 421-430.","journal-title":"Curr Opin Drug Discov Devel"},{"issue":"10","key":"412_CR10","doi-asserted-by":"publisher","first-page":"941","DOI":"10.2174\/1568026054985867","volume":"5","author":"I Popa-Burke","year":"2005","unstructured":"Popa-Burke I, Birkos S, Blackwell L, Cheatham L, Clark J, Dickson JK, Galasinski S, Janzen WP, Mendoza J, Miller JL, et al, et al.: Discovery of highly selective inhibitors of p38alpha. Curr Top Med Chem. 2005, 5 (10): 941-951. 10.2174\/1568026054985867","journal-title":"Curr Top Med Chem"},{"issue":"10","key":"412_CR11","doi-asserted-by":"publisher","first-page":"929","DOI":"10.2174\/1568026054985911","volume":"5","author":"DM Dambach","year":"2005","unstructured":"Dambach DM: Potential adverse effects associated with inhibition of p38alpha\/beta MAP kinases. Curr Top Med Chem. 2005, 5 (10): 929-939. 10.2174\/1568026054985911","journal-title":"Curr Top Med Chem"},{"issue":"8","key":"412_CR12","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.febslet.2008.01.063","volume":"582","author":"JJ Xu","year":"2008","unstructured":"Xu JJ, Hendriks BS, Zhao J, de Graaf D: Multiple effects of acetaminophen and p38 inhibitors: towards pathway toxicology. FEBS Lett. 2008, 582 (8): 1276-1282. 10.1016\/j.febslet.2008.01.063","journal-title":"FEBS Lett"},{"issue":"8","key":"412_CR13","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1517\/14728222.12.8.921","volume":"12","author":"S Duraisamy","year":"2008","unstructured":"Duraisamy S, Bajpai M, Bughani U, Dastidar SG, Ray A, Chopra P: MK2: a novel molecular target for anti-inflammatory therapy. Expert opinion on therapeutic targets. 2008, 12 (8): 921-936. 10.1517\/14728222.12.8.921","journal-title":"Expert opinion on therapeutic targets"},{"issue":"11","key":"412_CR14","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1021\/jm0611004","volume":"50","author":"DR Anderson","year":"2007","unstructured":"Anderson DR, Meyers MJ, Vernier WF, Mahoney MW, Kurumbail RG, Caspers N, Poda GI, Schindler JF, Reitz DB, Mourey RJ: Pyrrolopyridine inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2). Journal of medicinal chemistry. 2007, 50 (11): 2647-2654. 10.1021\/jm0611004","journal-title":"Journal of medicinal chemistry"},{"issue":"37","key":"412_CR15","doi-asserted-by":"publisher","first-page":"11658","DOI":"10.1021\/bi0495073","volume":"43","author":"W Davidson","year":"2004","unstructured":"Davidson W, Frego L, Peet GW, Kroe RR, Labadia ME, Lukas SM, Snow RJ, Jakes S, Grygon CA, Pargellis C, et al.: Discovery and characterization of a substrate selective p38alpha inhibitor. Biochemistry. 2004, 43 (37), et al: 11658-11671. 10.1021\/bi0495073","journal-title":"Biochemistry"},{"issue":"5196","key":"412_CR16","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1126\/science.7824938","volume":"267","author":"S Gupta","year":"1995","unstructured":"Gupta S, Campbell D, Derijard B, Davis RJ: Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science. 1995, 267 (5196): 389-393. 10.1126\/science.7824938","journal-title":"Science"},{"issue":"6783","key":"412_CR17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/35012097","volume":"405","author":"H Kawasaki","year":"2000","unstructured":"Kawasaki H, Schiltz L, Chiu R, Itakura K, Taira K, Nakatani Y, Yokoyama KK: ATF-2 has intrinsic histone acetyltransferase activity which is modulated by phosphorylation. Nature. 2000, 405 (6783): 195-200. 10.1038\/35012097","journal-title":"Nature"},{"issue":"4","key":"412_CR18","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/bies.20734","volume":"30","author":"SA Vlahopoulos","year":"2008","unstructured":"Vlahopoulos SA, Logotheti S, Mikas D, Giarika A, Gorgoulis V, Zoumpourlis V: The role of ATF-2 in oncogenesis. Bioessays. 2008, 30 (4): 314-327. 10.1002\/bies.20734","journal-title":"Bioessays"},{"issue":"8","key":"412_CR19","doi-asserted-by":"publisher","first-page":"5676","DOI":"10.1074\/jbc.M008787200","volume":"276","author":"WF Waas","year":"2001","unstructured":"Waas WF, Lo HH, Dalby KN: The kinetic mechanism of the dual phosphorylation of the ATF2 transcription factor by p38 mitogen-activated protein (MAP) kinase alpha. Implications for signal\/response profiles of MAP kinase pathways. J Biol Chem. 2001, 276 (8): 5676-5684. 10.1074\/jbc.M008787200","journal-title":"J Biol Chem"},{"issue":"4","key":"412_CR20","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/nsb770","volume":"9","author":"C Pargellis","year":"2002","unstructured":"Pargellis C, Tong L, Churchill L, Cirillo PF, Gilmore T, Graham AG, Grob PM, Hickey ER, Moss N, Pav S, et al, et al.: Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site. Nat Struct Biol. 2002, 9 (4): 268-272. 10.1038\/nsb770","journal-title":"Nat Struct Biol"},{"issue":"8","key":"412_CR21","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1021\/bi9919495","volume":"39","author":"G Chen","year":"2000","unstructured":"Chen G, Porter MD, Bristol JR, Fitzgibbon MJ, Pazhanisamy S: Kinetic mechanism of the p38-alpha MAP kinase: phosphoryl transfer to synthetic peptides. Biochemistry. 2000, 39 (8): 2079-2087. 10.1021\/bi9919495","journal-title":"Biochemistry"},{"issue":"7","key":"412_CR22","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nrm1962","volume":"7","author":"A Citri","year":"2006","unstructured":"Citri A, Yarden Y: EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol. 2006, 7 (7): 505-516. 10.1038\/nrm1962","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"412_CR23","doi-asserted-by":"publisher","first-page":"921","DOI":"10.2174\/1568026054985902","volume":"5","author":"GL Schieven","year":"2005","unstructured":"Schieven GL: The biology of p38 kinase: a central role in inflammation. Curr Top Med Chem. 2005, 5 (10): 921-928. 10.2174\/1568026054985902","journal-title":"Curr Top Med Chem"},{"issue":"9","key":"412_CR24","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1016\/j.molimm.2006.10.009","volume":"44","author":"W ten Hove","year":"2007","unstructured":"ten Hove W, Houben LA, Raaijmakers JA, Bracke M, Koenderman L: Differential regulation of TNFalpha and GM-CSF induced activation of P38 MAPK in neutrophils and eosinophils. Mol Immunol. 2007, 44 (9): 2492-2496. 10.1016\/j.molimm.2006.10.009","journal-title":"Mol Immunol"},{"issue":"1","key":"412_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/bjp.2008.53","volume":"154","author":"K Mihara","year":"2008","unstructured":"Mihara K, Almansa C, Smeets RL, Loomans EE, Dulos J, Vink PM, Rooseboom M, Kreutzer H, Cavalcanti F, Boots AM, et al.: A potent and selective p38 inhibitor protects against bone damage in murine collagen-induced arthritis: a comparison with neutralization of mouse TNFalpha. Br J Pharmacol. 2008, 154 (1): 153-164. 10.1038\/bjp.2008.53","journal-title":"Br J Pharmacol"},{"issue":"3","key":"412_CR26","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/jcp.1041590321","volume":"159","author":"EK Gallin","year":"1994","unstructured":"Gallin EK, Mason TM, Moran A: Characterization of regulatory volume decrease in the THP-1 and HL-60 human myelocytic cell lines. Journal of cellular physiology. 1994, 159 (3): 573-581. 10.1002\/jcp.1041590321","journal-title":"Journal of cellular physiology"},{"issue":"7","key":"412_CR27","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1096\/fasebj.12.7.553","volume":"12","author":"R Oehler","year":"1998","unstructured":"Oehler R, Zellner M, Hefel B, Weingartmann G, Spittler A, Struse HM, Roth E: Influence of heat shock on cell volume regulation: protection from hypertonic challenge in a human monocyte cell line. Faseb J. 1998, 12 (7): 553-560.","journal-title":"Faseb J"},{"issue":"4","key":"412_CR28","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.4049\/jimmunol.127.4.1515","volume":"127","author":"T Yasaka","year":"1981","unstructured":"Yasaka T, Mantich NM, Boxer LA, Baehner RL: Functions of human monocyte and lymphocyte subsets obtained by countercurrent centrifugal elutriation: differing functional capacities of human monocyte subsets. J Immunol. 1981, 127 (4): 1515-1518.","journal-title":"J Immunol"},{"issue":"1-3","key":"412_CR29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.febslet.2004.07.031","volume":"572","author":"S Morton","year":"2004","unstructured":"Morton S, Davis RJ, Cohen P: Signalling pathways involved in multisite phosphorylation of the transcription factor ATF-2. FEBS Lett. 2004, 572 (1-3): 177-183. 10.1016\/j.febslet.2004.07.031","journal-title":"FEBS Lett"},{"issue":"18","key":"412_CR30","doi-asserted-by":"publisher","first-page":"4631","DOI":"10.1111\/j.1742-4658.2005.04827.x","volume":"272","author":"AE Szafranska","year":"2005","unstructured":"Szafranska AE, Dalby KN: Kinetic mechanism for p38 MAP kinase alpha. A partial rapid-equilibrium random-order ternary-complex mechanism for the phosphorylation of a protein substrate. Febs J. 2005, 272 (18): 4631-4645. 10.1111\/j.1742-4658.2005.04827.x","journal-title":"Febs J"},{"issue":"31","key":"412_CR31","doi-asserted-by":"publisher","first-page":"9950","DOI":"10.1021\/bi049508v","volume":"43","author":"SM Lukas","year":"2004","unstructured":"Lukas SM, Kroe RR, Wildeson J, Peet GW, Frego L, Davidson W, Ingraham RH, Pargellis CA, Labadia ME, Werneburg BG: Catalysis and function of the p38 alpha. MK2a signaling complex. Biochemistry. 2004, 43 (31): 9950-9960. 10.1021\/bi049508v","journal-title":"Biochemistry"}],"container-title":["BMC Systems Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-0509-4-23.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1752-0509-4-23\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-0509-4-23.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:33:19Z","timestamp":1685493199000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcsystbiol.biomedcentral.com\/articles\/10.1186\/1752-0509-4-23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,15]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["412"],"URL":"https:\/\/doi.org\/10.1186\/1752-0509-4-23","relation":{},"ISSN":["1752-0509"],"issn-type":[{"value":"1752-0509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,15]]},"article-number":"23"}}